Preclinical development and characterization of a human plasma-derived high-purity factor X concentrate for therapeutic use.

Lloyd, Joanne; Feldman, Peter

Lloyd, Joanne; Feldman, Peter.

Affiliation

Lloyd J; Research & Development Department, Bio Products Laboratory, Dagger Lane, Elstree, UK.
Feldman P; Research & Development Department, Bio Products Laboratory, Dagger Lane, Elstree, UK.

Haemophilia ; 29(6): 1394-1409, 2023 Nov.

Article in En | MEDLINE | ID: mdl-37766495

Subject(s)

Factor X Deficiency; Factor X; Humans; Factor X/therapeutic use; Factor X Deficiency/drug therapy; Factor X Deficiency/complications; Hemorrhage/complications; Plasma; Pharmaceutical Preparations

Key words

blood proteins; factor X deficiency; orphan drug production; pharmaceutical preparations; therapeutics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor X / Factor X Deficiency Type of study: Guideline Limits: Humans Language: En Journal: Haemophilia Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google